http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1227808-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f06faeb9c558d826cf1f19ce4103d13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-664
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
filingDate 2000-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0b0f35aff47ad74657ab7d2bf8b8950
publicationDate 2002-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1227808-A2
titleOfInvention Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation
abstract The invention relates to the use of treosulfan as a conditioning agent before allogenic transplantation of bone marrow or haematopoietic stem cells, whereby treosulfan is administered, either as single effective agent, or in combination with other chemotherapetic agents or immunosuppressant agents.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4257122-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020064815-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020064819-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020064816-A1
priorityDate 1999-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228809183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57186428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9554281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228809181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127647723
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127960150
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30751
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID460612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20517135
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127441657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135991775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136050722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396384

Total number of triples: 55.